New molecular breast imaging study highlights Cardiolite

09/9/2008 | Medical News Today

A new study on molecular breast imaging featuring Lantheus Medical Imaging's molecular imaging agent Cardiolite was scheduled to be presented Sunday at the American Society of Clinical Oncology's 2008 Breast Cancer Symposium. The study provides "encouraging data for millions of women and families who are impacted by breast cancer and sheds light on potential new diagnostic approaches for finding tumors in women who have dense breast tissue, which can confound mammograms," Lantheus CEO Don Kiepert said.

View Full Article in:

Medical News Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA